Health care resource utilization and health care costs among digital weight-loss intervention participants and nonparticipants.

Casey Tak^1,2, Paige Thompson², Jessica L Morse², Meaghan McCallum²

¹Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA.

²Noom Inc., Princeton, New Jersey, USA.

Abstract

OBJECTIVE: The objective of this study was to compare health care resource utilization (HRU), health care costs, and glucagon-like peptide-1 (GLP-1) agonist use among working US adults who engaged in Noom Weight, a smartphone-based lifestyle intervention for weight management, to individuals offered Noom who did not enroll. METHODS: Insurance claims data were used to conduct retrospective analyse…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.